Upcoming Events
Pharma Monopoly: The Battle for the Future of Medicines
Tahir Amin discusses his new book on how to change the pharmaceutical industry for the better.
Tahir Amin and Rohit Malpani, two leading figures in the access to medicines movement, examine the origins of this system of rules that champions monopolies and innovation over the public interest and human well-being. They tell the story of how, move by move, governments have ceded control to and then empowered pharmaceutical companies, making it increasingly hard to undo the damage wreaked along the way. From their unique vantage points and experiences, the authors critique global health initiatives and philanthropists for maintaining the status quo and warn of a future dominated by financial markets and artificial intelligence that will reinforce the worst practices of yesterday and portends new injustices for everyone.
This event is co-sponsored by the Intellectual Property & Entertainment Law Society.
This event is governed by the Engelberg Center's Code of Conduct and NYU's COVID policies. KN95 masks and Covid-19 rapid tests will be available for attendees.
NYU Law provides reasonable accommodations to people with disabilities. Requests for accommodations for events and services should be submitted at least two weeks before the date of the accommodation needed. Please email engelberg.center@nyu.edu for assistance.
Monopoly Medicine & the Affordability Crisis
Join us for a happy hour conversation on corporate power, healthcare costs, and the fight for affordability.
Tahir Amin (co-founder, I-MAK; co-author, Pharma Monopoly) and Gaby Aboulafia (ESP Healthcare Fellow) discuss what's driving the crisis and how public pharma can build a path to affordability.
📍 Bibliotheque, 54 Mercer Street, NYC
🗓️ Tuesday, October 20, 5-7pm
Space is limited.
The Health Justice Initiative
PHARMA MONOPOLY challenges the dominant narratives of intellectual property, the false god of innovation, and philanthropy that have created or reinforced inequities and injustices. It also provides a warning of a neo-feudalism that is to come with the emergence of AI in the field of medicines and offers a powerful call for a new movement for justice in global health.
Join us at The Book Lounge on July 16 for an evening with Tahir Amin in conversation with Fatima Hassan and Leena Menghaney.
Washington DC Book Launch
Billions of people lack the freedom to access affordable life-saving medicines. One third of Americans leave prescriptions unfilled due to costs, often skipping doses or cutting pills in half just to get by.
In PHARMA MONOPOLY, Tahir Amin and co-author Rohit Malpani pull back the curtain on a system that prioritizes power and profit over human well-being. This isn’t just about the pharmaceutical industry—it’s about how access to medical care has been remade by private interests both in the U.S. and abroad, how governments have ceded control to monopolies, and how global health initiatives often maintain a status quo that leaves the most vulnerable behind while cementing existing power structures.
Through a critical look at historical events, including drawing on Tahir’s two decades in the global access to medicines movement from Delhi to Geneva to Capitol Hill, PHARMA MONOPOLY traces how the ideology of neoliberalism pushed by western governments under the guise of a rules based order operated as a form of colonialism that shaped global trade and the modern pharmaceutical industry over the last 50 years.
PHARMA MONOPOLY challenges the dominant narratives of intellectual property, the false god of innovation, and philanthropy that have created or reinforced inequities and injustices. It also provides a warning of a neo-feudalism that is to come with the emergence of AI in the field of medicines and offers a powerful call for a new movement for justice in global health.
Join us at the Hopkins Bloomberg Center on June 25 for an evening with Tahir Amin in conversation with Oxfam's Director of Economic and Racial Justice, Nabil Ahmed.
RSVP Here
NYC Book Launch
Billions of people lack the freedom to access affordable life-saving medicines. One third of Americans leave prescriptions unfilled due to costs, often skipping doses or cutting pills in half just to get by.
In PHARMA MONOPOLY, Tahir Amin and co-author Rohit Malpani pull back the curtain on a system that prioritizes power and profit over human well-being. This isn't just about the pharmaceutical industry—it’s about how access to medical care has been remade by private interests both in the U.S. and abroad, how governments have ceded control to monopolies, and how global health initiatives often maintain a status quo that leaves the most vulnerable behind while cementing existing power structures.
Through a critical look at historical events, including drawing on Tahir’s two decades in the global access to medicines movement from Delhi to Geneva to Capitol Hill, PHARMA MONOPOLY traces how the ideology of neoliberalism pushed by western governments under the guise of a ‘rules based order’ operated as a form of colonialism that shaped global trade and the modern pharmaceutical industry over the last 50 years.
PHARMA MONOPOLY challenges the dominant narratives of intellectual property, the false god of innovation, and philanthropy that have created or reinforced inequities and injustices. It also provides a warning of a neo-feudalism that is to come with the emergence of AI in the field of medicines and offers a powerful call for a new movement for justice in global health.
Join us at The People’s Forum on June 11th for an evening with Tahir Amin, in conversation with South African activist-scholar-author, A. Kayum Ahmed.